Similar articles

• Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.

  Celik T, Iyisoy A, Yuksel UC, Isik E. Celik T, et al. Int J Cardiol. 2009 Jan 9;131(2):269-70; author reply 271-2. doi: 10.1016/j.ijcard.2007.05.103. Epub 2007 Aug 10. Int J Cardiol. 2009. PMID: 17692947
• Myocardial revascularization by percutaneous coronary intervention: past, present, and the future.

  Singh IM, Holmes DR Jr. Singh IM, et al. Curr Probl Cardiol. 2011 Oct;36(10):375-401. doi: 10.1016/j.cpcardiol.2011.05.005. Curr Probl Cardiol. 2011. PMID: 21889660 Review.
• [Myocardial revascularization in the early XXIst century: less and less bypass indications].

  Monassier JP, Monassier F. Monassier JP, et al. Presse Med. 2008 Nov;37(11):1575-9. doi: 10.1016/j.lpm.2008.03.012. Epub 2008 Sep 10. Presse Med. 2008. PMID: 18786805 French. No abstract available.
• Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.

  Sobel BE. Sobel BE. Coron Artery Dis. 2010 May;21(3):189-98. doi: 10.1097/MCA.0b013e3283383ebe. Coron Artery Dis. 2010. PMID: 20308880 Review.
• Evaluating risks and benefits in coronary revascularisation--a very imperfect art?

  de Belder MA, Hamilton L. de Belder MA, et al. Heart. 2009 Jan;95(1):6-8. doi: 10.1136/hrt.2007.141440. Epub 2008 Sep 3. Heart. 2009. PMID: 18768566 No abstract available.